(Q30358639)

English

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

scientific article

Statements

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study. (English)
Andre Goy
Rajni Sinha
Michael E Williams
Sevgi Kalayoglu Besisik
Johannes Drach
Radhakrishnan Ramchandren
Lei Zhang
Sherri Cicero
Tommy Fu
Thomas E Witzig
3 September 2013
3688-3695

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit